Page 180 - Biomedical Engineering and Design Handbook Volume 2, Applications

DESIGN OF ARTIFICIAL KIDNEYS 159

11. Henrich W: Prinicples and Practice of Dialysis, Philadelphia, Pa. Lippincott Williams & Wilkins, 3d ed., 2004.
12. Ronco C: Backfiltration: a controversial issue in modern dialysis. Int. J. Artif. Org. 11:69–74, 1988.
13. Ronco C, Levin NW: Hemodialysis, Vascular Access, and Peritoneal Dialysis Access. New York, N.Y., Basel, 2004.
14. Cappelli G, Inguaggiato P, Ferramosca E, Albertazzi A: Water treatment for hemodialysis, in Ronco C, Greca
L (eds.), Hemodialysis Technology. Basel, Karger, 2002, pp. 317–324.
15. Wber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D: Pyrogen transfer across high and low flux
hemodialysis membranes. Artif. Organs. 28:210–217, 2004.
16. Schindler R, Christ-Kohlrausch F, Frei U, Shaldon S: Differences in permeability of high-flux dialyzer mem-
branes for bacterial pyrogens. Clin. Nephrol. 59:447–454, 2003.
17. Schindler R: Causes and therapy of microinflammation in renal failure. Nephrol. Dial. Transpl. 19(Suppl.
5):34–40, 2004.
18. Woods HF, Nandakumar M: Improved outcome for hemodialysis patients treated with high-flux membranes.
Nephrol. Dial. Traspl. 15(Suppl. 1):36–42, 2000.
19. Akizawa T, Kinugasa E, Ideura T: Classification of dialysis membranes by performance. Contrib. Nephrol.
113:25–31, 1995.
20. Clark WR, Hamburger RJ, Lysaght MJ: Effect of membrane composition and structure on solute removal
and biocompatibility in hemodialysis. Kidney Int. 56:2005–2015, 1999.
21. Leypoldt JK, Cheung AK: Characterization of molecular transport in artificial kidney. Art. Org. 20:381–389,
1996.
22. Clark WR, Macias WL, Molitoris BA, Wang NH: Plasma-protein adsorption to highly permeable hemodial-
ysis membranes. Kidney Int. 48:481–488, 1995.
23. Cooney D: Biomedical Engineering Principles. New York, N.Y., M. Dekker, 1976.
24. Vienken J, Bowry S: Quo vadis dialysis membrane? Artif. Organs. 26:152–159, 2002.
25. Sharma CP: Membranes for dialysis, in Encyclopedia of Surface and Colloid Science. Dekker, 2004, pp. 1–15.
26. Cases A, Reverter J, Escolar G, Sanz C, Sorribes C, Ordinas A: In-vivo evaluation of platelet activation by
different cellulosic membranes. Art. Organs, 21:330–334, 1997.
27. Cheung AK, Parker CJ, Wilcox L, Janatova J: Activation of the alternate pathway of complement by cellu-
losic membranes. Kidney Int. 36:257–265, 1989.
28. Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesaei J, De Walele M: Evaluation of platelets
and hemostasis during hemodialysis with six different membranes. Nephron. 59:567–572, 1991.
29. Sirolli V, Di Stante S, Stuard S, Stuard S, Di Liberato L, Amoroso L, Cappelli P, Bonomini M:
Biocompatibility and functional performance of polythene glycol acid-grafted cellulose: An alternative to
synthetic membranes for use in hemodialysis. Int. J. Art. Organs. 23:356–364, 2000.
30. Sasaki M, Hosoya N, Saruhasi, M: Vitamin E modified cellulose membrane. Art. Organs. 24:779–789, 2000.
31. Zaluska WT, Ksiazek A, Rolski J: Effect of vitamin E modified cellulose membrane on human lymphocyte,
monocyte, and granulocyte CD11b/CD18 adhesion molecule expression during hemodialysis. ASAIO J.
47:619–622, 2001.
32. Dhondt A, Vanholder R, Florieux G, Waterloos MA, De Smet R, Lesaffer G, Lameire N: Vitamin E-bonded
cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of
leukocyte surface molecules. Am. J. Kidney Dis. 36:1140–1146, 2000.
33. Hakim NA: Influence of hemodialysis membrane on outcome of ESRD patients. Am. J. Kidney Dis.
32:71–75, 1998.
34. Cianciolo G, Stefoni S, Donati G, De Pascalis A, Iannelli S, Manna C, Coli L, et al. Intra- and post-dialytic
platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol. Dial.
Transplant. 16(6):1222–1229, June 2001.
35. Jaber BL, Fonski JA, Cendorogio M, Balakrishnan VS, Razegi, P, Dinarello, CA, Pereira BJ: New polyether
sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas contaminated
dialysate. Blood Purif. 16:210–219, 1998.
36. Kanda H, Kubo K, Hamasaki K, Kanda A, Nakao A, Kitamura T, Fujita T, Yamamoto K, Mimura T:
Influence of various hemodialysis membranes on the plasma (1–3-D)-glucan level. Kidney Int. 60:319, 2001.
37. Falkenhagen D, Brown GS: Clinical evaluation of three hemodialyzers containing PMMA membranes of differ-
ent surface area, with special attention to thrombogenicity. Nephrol. Dial. Transplant. 6(Suppl. 2):43–8, 1991.